LivaNova PLC Cash and Restricted Cash
LivaNova PLC (LIVN) had Cash and Restricted Cash of $516.62 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-05
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $516.62M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $539.71M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $635.55M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $646.08M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2026-06-30 | $516.62M 10-Q · filed 2026-08-05 |
| 2026-03-31 | $539.71M 10-Q · filed 2026-05-06 |
| 2025-12-31 | $635.55M 10-Q · filed 2026-08-05 |
| 2025-09-30 | $646.08M 10-Q · filed 2025-11-05 |
| 2025-06-30 | $593.64M 10-Q · filed 2026-08-05 |
| 2025-03-31 | $738.44M 10-Q · filed 2026-05-06 |
| 2024-12-31 | $723.56M 10-Q · filed 2026-08-05 |
| 2024-09-30 | $666.58M 10-Q · filed 2025-11-05 |
| 2024-06-30 | $633.12M 10-Q · filed 2025-08-06 |
| 2024-03-31 | $615.68M 10-Q · filed 2025-05-07 |
| 2023-12-31 | $577.87M 10-K · filed 2026-02-25 |
| 2023-09-30 | $532.72M 10-Q · filed 2024-10-31 |
| 2023-06-30 | $534.36M 10-Q · filed 2024-08-01 |
| 2023-03-31 | $522.96M 10-Q · filed 2024-05-03 |
| 2022-12-31 | $515.62M 10-K · filed 2026-02-25 |
| 2022-09-30 | $506.28M 10-Q · filed 2023-11-01 |
| 2022-06-30 | $406.77M 10-Q · filed 2023-07-26 |
| 2022-03-31 | $442.38M 10-Q · filed 2023-05-03 |
| 2021-12-31 | $207.99M 10-K · filed 2025-02-25 |
| 2021-09-30 | $181.85M 10-Q · filed 2022-11-02 |
| 2021-06-30 | $329.39M 10-Q · filed 2022-08-03 |
| 2021-03-31 | $252.54M 10-Q · filed 2022-05-04 |
| 2020-12-31 | $252.83M 10-K · filed 2024-02-29 |
| 2020-09-30 | $227.81M 10-Q · filed 2021-11-03 |
| 2020-06-30 | $232.55M 10-Q · filed 2021-07-28 |
| 2020-03-31 | $125.82M 10-Q · filed 2021-04-28 |
| 2019-12-31 | $61.14M 10-K · filed 2023-02-27 |
| 2019-09-30 | $75.31M 10-Q · filed 2020-10-29 |
| 2019-06-30 | $44.51M 10-Q · filed 2020-07-29 |
| 2019-03-31 | $50.78M 10-Q · filed 2020-04-30 |
| 2018-12-31 | $47.20M 10-K · filed 2022-03-01 |
| 2018-09-30 | $79.95M 10-Q · filed 2019-10-30 |
| 2018-06-30 | $47.38M 10-Q · filed 2019-07-31 |
| 2018-03-31 | $64.96M 10-Q · filed 2019-05-01 |
| 2017-12-31 | $93.61M 10-K · filed 2021-03-01 |
| 2016-12-31 | $39.79M 10-K · filed 2020-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |